Developing effective antimalarials to
save lives
Tracking Progress in Scaling-Up Diagnosis and Treatment for Malaria.
A new report commissioned by MMV and RBM.
UK companies tackle MDG 6: Combat HIV/AIDS, malaria and other diseases.
Read this new report that highlights innovative approaches being undertaken by UK business.
When Is Enough Enough? The Need for a Robust Pipeline of High-quality Antimalarials.
Read the article published in Discovery Medicine.
With just 5 years left to reach the MDG deadline, how close are we to achieving the goals?
Read MMV’s views recently published in the Commonwealth Health Ministers update.
Annual Report 2009
Read up-to-date articles highlighting our activities in 2009 and the financial statement for that year.
News
MMV will contribute intellectual property to the Pool for Open Innovation Against Neglected Tropical Diseases.
16 August 2010
MMV and Ferrer, one of Spain’s major pharmaceutical groups, have agreed to explore the Ferrer compound library for promising molecules that could be developed into novel medicines needed to defeat malaria.
15 July 2010
MMV and Malawi Ministry of Health sow the seeds for a fruitful collaboration.
14 July 2010
Through access to AstraZeneca’s extensive compound library, MMV will seek to identify promising compounds with the potential to treat malaria.
28 June 2010
